CASI Pharmaceuticals(CASIF)
$0.100.00 (0.00%)
CASIF
CASI Pharmaceuticals financials statements
$0.10
At close:0.00 (0.00%)
Want to see CASIF full AI Analyst Report?
CASI Pharmaceuticals (CASIF) Income Statement
480 Followers
CASI Pharmaceuticals Income Statement
Last quarter (Q2 2026), CASI Pharmaceuticals's total revenue was $4.91M, an increase of 17.57% from the same quarter last year. In Q2, CASI Pharmaceuticals's net income was $-10.02M. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 20.71M | $ 28.54M | $ 33.88M | $ 43.11M | $ 30.17M | |
| $ 10.06M | $ 11.15M | $ 20.05M | $ 27.28M | $ 17.61M | |
| $ 52.90M | $ 50.77M | $ 45.13M | $ 53.77M | $ 59.13M | |
| Depreciation and Amortization | $ 1.26M | $ 2.33M | $ 3.74M | $ 2.42M | $ 1.81M |
| $ -43.77M | $ -34.87M | $ -21.54M | $ -35.79M | $ -33.40M | |
| $ -42.85M | $ -39.62M | $ -25.08M | $ -26.49M | $ -41.52M | |
| $ -5.21M | $ 1.55M | $ -1.21M | $ -11.79M | $ 5.67M | |
| $ -48.06M | $ -38.07M | $ -26.29M | $ -38.28M | $ -35.84M | |
| $ -48.06M | $ -39.26M | $ -26.94M | $ -41.01M | $ -36.65M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.59 | $ -2.56 | $ -2.02 | $ -3.01 | $ -2.69 |
| Diluted EPS | $ -2.59 | $ -2.56 | $ -2.02 | $ -3.01 | $ -2.69 |
| Weighted Average Shares Outstanding | 18.54M | 15.34M | 13.36M | 13.65M | 13.61M |
| Weighted Average Shares Outstanding (Diluted) | 18.54M | 15.34M | 13.36M | 13.65M | 13.61M |
Currency in USD
